SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivian is generating significant community attention following an upbeat revenue forecast and an upward revision to its annual delivery guidance, which has fueled a debate over whether these positive operational updates justify recent share dilution or if the stock remains a high-volatility trading vehicle. Investors are heavily focused on the company's scaling potential and the upcoming R2 launch, while discussions remain polarized between long-term bulls betting on a fundamental turnaround and skeptical traders concerned about the repeated pattern of capital raises capping rally momentum.

Compass Pathways Plc is a biotechnology company, which provides mental health care services. It focuses on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. The company was founded by Goldsmith George Jay and Malievskaia Ekaterina in 2016 and is headquartered in London, the United Kingdom.

Compass Pathways Plc - ADR

COMPASS Pathways

COMPASS Pathways is currently seeing high investor interest fueled by a combination of positive clinical data and favorable regulatory tailwinds, including a rolling FDA review and a new priority designation for their psilocybin-based depression therapy. The community is actively discussing the stock's potential for a significant re-rating, with many focusing on the upcoming durability trial data, the company's strong cash position, and growing institutional confidence in the sector.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Nvidia is trending as investors weigh conflicting signals between reports of potential product delays and the company's firm rebuttal that its AI infrastructure roadmap remains intact. Market sentiment is heavily divided, with some community members frustrated by the stock's recent volatility and alleged price manipulation, while others maintain conviction in the long-term fundamentals of the AI compute cycle.

Crinetics Pharmaceuticals, Inc. operates as a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. The firm's product candidate, CRN00808, is an oral nonpeptide somatostatin agonist for the treatment of acromegaly. It is also developing other oral nonpeptide somatostatin agonists for neuroendocrine tumors and hyperinsulinism, as well as an oral nonpeptide ACTH antagonist for the treatment of Cushing's disease. The company was founded by R. Scott Struthers, Yun-Fei Zhu and Stephen F. Betz in 2008 and is headquartered in San Diego, CA.

Crinetics Pharmaceuticals Inc

Crinetics Pharmaceuticals is trending following a massive $10 billion acquisition by Vertex Pharmaceuticals, a deal that represents a significant premium for shareholders. Investors are now actively debating whether to lock in gains or monitor the stock for potential merger arbitrage opportunities as the sector continues to see intense M&A activity.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

SOXL is facing intense volatility as traders debate whether the current semiconductor pullback is a temporary buying opportunity for the AI cycle or the beginning of a deeper trend reversal. The community is sharply divided, with many actively trading the aggressive swings while others warn of technical breakdown and further downside risk.

Lumen Technologies, Inc. is an investment holding company, which engages in the provision of integrated communications to residential and business customers. It operates through the Business and Mass Markets segments. The Business segment provides products and services under four sales channels to enterprise and commercial customers. The Mass Markets segment focuses on consumer and small business customers. The company was founded in 1930 and is headquartered in Monroe, LA.

Lumen Technologies Inc

Lumen Technologies is experiencing significant volatility following the completion of its Alkira acquisition, which aims to integrate software-defined networking into its AI-focused fiber infrastructure. While management positions this as a strategic pivot toward higher-margin software services, investors are actively debating whether this heavy capital expenditure strategy will deliver on promised revenue inflection points or continue to burden the balance sheet.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Cloud Memory Business Unit (CMBU), Core Data Center Business Unit (CDBU), Mobile and Client Business Unit (MCBU), and Automotive and Embedded Business Unit (AEBU). The CMBU segment focuses on memory solutions for large hyperscale cloud customers and High-Bandwidth Memory for all data center customers. The CDBU segment is involved in memory solutions for mid-tier cloud, enterprise, and OEM data center customers and storage solutions for all data center customers. The MCBU segment focuses on memory and storage solutions for the mobile and client segments. The AEBU segment is involved in memory and storage solutions for the automotive, industrial, and consumer segments. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is trending as a broader semiconductor sell-off, sparked by Samsung's earnings and concerns over AI cycle sustainability, triggers heavy volatility. Investors are actively debating whether this pullback is a temporary reset for long-term growth or the beginning of a larger correction, with many retail participants discussing whether to capitalize on the dip or brace for further downside.

Duos Technologies Group, Inc. designs, develops, deploys, and operates intelligent technology solutions supporting rail, logistics, intermodal and government customers that streamlines operations, improves safety and reduces costs. It offers imaging, safety and security, software, and services. The firm also provides cutting edge solutions that automate the mechanical and security inspection of fast moving trains, trucks and automobiles through a broad range of proprietary hardware, software, information technology and artificial intelligence. The company was founded on May 31, 1994 and is headquartered in Jacksonville, FL.

Duos Technologies Group Inc

Duos Technologies is gaining significant market attention as it scales its modular edge data center deployments, with recent news highlighting a new installation in Texas and growing demand from K-12 school districts and regional carriers. The community is actively discussing the company's competitive advantage in avoiding the power, noise, and zoning bottlenecks that have stalled larger, traditional data center projects across the country.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk is experiencing significant volatility as investors debate whether the current pullback is a healthy consolidation within a long-term memory supercycle or a signal that the AI-driven rally has peaked. Community sentiment remains deeply divided, with many traders viewing the dip as a prime buying opportunity supported by strong earnings potential, while others fear further downside pressure amid concerns over global memory production capacity and institutional profit-taking.

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.

Vertex Pharmaceuticals, Inc.

Vertex Pharmaceuticals is in focus following a definitive $10 billion agreement to acquire Crinetics Pharmaceuticals, a strategic move that expands its rare disease pipeline into the endocrinology sector with promising late-stage assets. Investors are actively debating the 100% acquisition premium and Vertex's long-term strategy, while technical analysts highlight the stock's potential for a rally as it strengthens its market position.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$DELL this is just getting to easy…. Keep selling, 350 this week, 200 and lower by year end

StockTwits for iOS

Dell Technologies Inc

 this is just getting to easy…. Keep selling, 350 this week, 200 and lower by year end